Radiotherapy of patients with prostate cancer offers an alternative to radi
cal prostatectomy in early stages (T1-T2). In locally advanced prostate can
cer a high dose or combined radiotherapy is more effective than radical sur
gery with concurrent lower morbidity and mortality. Recent developments in
linear accellerator technique, the progress in dose calculation and plannin
g techniques provide the means to apply higher doses to a given tumor volum
e while effectively protecting the surrounding normal tissue at the same ti
me. These improvements may possibly reduce the rate of therapy related side
effects or complications significantly. The combination of external beam r
adiotherapy and interstitial brachytherapy as well as the combination of ho
rmone therapy and external beam radiotherapy are most likely more effective
than percutaneous irradiation alone. In special cases with a very low risk
of recurrent tumor an interstitial permanent brachytherapy alone is indica
ted. Future developments (i.e. intensity modulated radiotherapy - IMRT, com
bined thermo-radiotherapy, proton- or neutrontherapy) may further increase
the rate of curative treatments in patients with prostate cancer.